NextCure Inc. (NXTC)
NASDAQ: NXTC
· Real-Time Price · USD
0.45
-0.05 (-10.38%)
At close: Jun 17, 2025, 3:59 PM
-10.38% (1D)
| Bid | 0.34 |
| Market Cap | 12.75M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -49.52M |
| EPS (ttm) | -1.77 |
| PE Ratio (ttm) | -0.26 |
| Forward PE | -0.48 |
| Analyst | Buy |
| Ask | 0.55 |
| Volume | 346,159 |
| Avg. Volume (20D) | 239,204 |
| Open | 0.50 |
| Previous Close | 0.50 |
| Day's Range | 0.45 - 0.48 |
| 52-Week Range | 0.22 - 1.82 |
| Beta | 1.08 |
About NXTC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NXTC
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NXTC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
NextCure shares are trading higher after the compa...
Unlock content with
Pro Subscription
9 months ago
NextCure shares are trading lower. The company announced results from its Phase 1b study of NC410.
